Patent Term Extension Application for PROLIA® (denosumab), U.S. Patent No. 7,411,050

Docket ID: FDA-2011-E-0014
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Keyword(s): cder, U.S. Patent No. 7,411,050, denosumab, PROLIA® , Patent Term Extension Application
Type: Nonrulemaking
Docket Status: OPEN
Center: CDER
Docket Item Code: E

Primary Documents

View All  (9)
Comment Period Closed
Jul 06, 2012 11:59 PM ET
Posted: 05/07/2012
ID: FDA-2011-E-0014-0006
Comment Period Closed
Posted: 02/24/2015
ID: FDA-2011-E-0014-0009
Comment Period Closed
Posted: 07/02/2014
ID: FDA-2011-E-0014-0008
Comment Period Closed
Posted: 12/27/2012
ID: FDA-2011-E-0014-0007
Comment Period Closed
Posted: 04/18/2012
ID: FDA-2011-E-0014-0005

Supporting Documents

No documents available.


No comments posted.

Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.